3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
11
Breast Neoplasms
8
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
3
Pancreatic cancer, adult
2
Ovarian Neoplasms
2
Lymphoma
2
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Stroke
1
Skin Neoplasms
1
Sezary Syndrome
1
Retroviridae Infections
1
Renal Insufficiency
1
Prostate Cancer Metastatic
1
Pancreatic carcinoma, familial
1
Pancreatic Neoplasms
1
Ovarian Germ Cell Cancer
1
Oligomenorrhea
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Cells, Circulating
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm, Residual
1
Interventions
Blood Specimen Collection
6
Liquid Biopsy
3
Chemotherapy, Adjuvant
2
trastuzumab deruxtecan
1
pegaspargase
1
Vincristine
1
Trastuzumab
1
Transplantation, Autologous
1
Prednisone
1
Neoadjuvant Therapy
1
Methotrexate
1
Mercaptopurine
1
Hematologic Tests
1
Drug Therapy
1
Doxorubicin
1
Daunorubicin
1
Cytoreduction Surgical Procedures
1
Cytarabine
1
Cyclophosphamide
1
Clonal Evolution
1
Anti-Inflammatory Agents, Non-Steroidal
1
Aminolevulinic Acid
1
Ado-Trastuzumab Emtansine
1
Adjuvants, Pharmaceutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasm, Residual
×
Hematologic Tests
×
Clear all
NCT07514715
2026-04-13
RT4
The Lymphoma Academic Research Organisation
Not yet recruiting
129 enrolled